ValueQ4, 24Q1, 25Q2, 25TTMSelling/general/admin expenses196.64 M116.21 M113.69 M577.81 MResearch & development26.03 M24.24 M23.13 M97.98 MOperating income-23.86 M47.66 M54.46 M116.97 MNon-Operating Income, Total1 M333 K-3.68 M-2.78 MInterest expense, net of interest capitalized2.18 M2.93 M2.17 M9.29 MNon-Operating Income, excl. Interest Expenses2.36 M-2.6 M-5.85 M-8.53 MUnusual income/expense-3.54 M———Pretax income-22.86 M47.99 M50.78 M114.19 MEquity in earnings1.11 M294 K110 K922 KTaxes-5.18 M9.81 M12.78 M33.09 MNon-controlling/minority interest0———After tax other income/expense————Net income before discontinued operations-17.68 M35.59 M38.01 M78.5 MDiscontinued operations—2.6 M0—Net income-17.68 M38.19 M38.01 M81.1 MDilution adjustment————Preferred dividends————Diluted net income available to common stockholders-17.7 M38.18 M38 M81.06 MBasic earnings per share (Basic EPS)-0.10.250.240.53Diluted earnings per share (Diluted EPS)-0.110.240.240.51Average basic shares outstanding157.52 M155.46 M155.84 M626.2 MDiluted shares outstanding159.72 M156.36 M157 M632.02 MEBITDA3.25 M72 M79.17 M220.7 MEBIT-23.86 M47.66 M54.46 M116.97 MCost of revenue118.15 M98.44 M104.6 M422.82 MOther cost of goods sold————Depreciation & amortization (cash flow)27.11 M24.34 M24.71 M103.73 M
Bio-Techne Corp
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.